Status: Recruiting
A Study of Olezarsen for the Treatment of Familial Chylomicronemia Syndrome (FCS) in Pediatric Participants
The primary purpose of the study is to evaluate the efficacy of olezarsen administered by subcutaneous injection to pediatric participants with FCS.
Participants needed: 12
Trial details
Phase: Phase 3Age: 2-17Biological sex: AllType: InterventionalSponsor: Ionis Pharmaceuticals, Inc.Updated: Aug 18, 2026Locations: 4
Eligibility criteria
Parental or legally authorized representative consent must be obtained, and the... [+5]
Newly diagnosed within 12 weeks prior to screening or during the screening perio... [+9]